Delivery Order SPE2DB22D2007-SPE2DB25FJ3UG
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Verapamil SR 180 mg capsules (100-count units) with a ceiling value of $2,049.48. This contract represents a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.19 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Verapamil ER PM 300 mg capsules (100-count units). This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Verapamil ER PM 300 mg capsules (100-count units) with a ceiling value of $1,424.91 and an ultimate completion date of August 4, 2025. This is a firm fixed price delivery order with no set-aside designation, reflecting open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,745.58 firm fixed-price delivery order is for the supply of 100 units of Verapamil SR 360 mg capsules. The contract has an ultimate completion date of May 5, 2025 and is not set-aside. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,750.01 firm fixed-price delivery order is for the supply of 4567721345 VERAPAMIL SR 360 MG CAPSULE 100S. The award has an ultimate completion date of March 28, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency has awarded a delivery order valued at $2,723.92 to AmerisourceBergen Drug Corp for the supply of Verapamil 5 mg/2 ml vials. This firm fixed price delivery order, issued on July 18, 2025, represents a non-competitive, non-set-aside award to the pharmaceutical distributor's Conshohocken, Pennsylvania location, with an ultimate completion date of July 21, 2025. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $143,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561598257 Verapamil SR 180 mg capsules in quantities of 100. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 25, 2023 through July 26, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency manages the global supply chain for the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,596.20, is for the delivery of verapamil 5 mg/2 ml vials. The contract has a completion date of February 19, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.40 firm fixed-price contract is for the supply of 4560954744 - VERAPAMIL SR 360 MG CAPSULE 100S, a cardiovascular medication. The award is part of AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range of pharmaceutical products and...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $187.09 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 100 capsules of 240mg Verapamil SR. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from August 4-7, 2023. No subcontractors or set aside designations were identified. The Defense Logistics Agency...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3UGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Verapamil SR 180 mg capsules (100 count) with a ceiling value of $1,691.01 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of August 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This award exemplifies AmerisourceBergen's role as a critical pharmaceutical distributor within the Defense Logistics Agency's Medical Supply Chain, supporting military and federal healthcare systems. AmerisourceBergen holds a significant $999.999 billion IDC with DLA Troop Support Medical (designation SPE2DX) extending through December 2026, which serves as the overarching contract vehicle enabling delivery orders for a comprehensive range of pharmaceutical products and medical supplies globally. The company's federal procurement portfolio demonstrates consistent capability to fulfill competitive pharmaceutical supply requirements across multiple therapeutic domains for defense and healthcare missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/8/25 |